Sorbent Therapeutics Secures $6,000,000 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=19db2039-a9c7-4e3c-bcf0-63bc608aedce&Preview=1 - Date
6/11/2012 - Company Name
Sorbent Therapeutics - Mailing Address
710 Lakeway Drive Sunnyvale, CA 94085 - Company Description
Sorbent Therapeutics is a biopharmaceutical company focused on the development of adaptable non-absorbed polymeric drugs to satisfy unmet clinical needs in large markets such as End Stage Renal Disease (ESRD), Congestive Heart Failure (CHF), Chronic Kidney Disease (CKD), and Hypertension. - Website
http://www.sorbentrx.com - Transaction Type
Debt - Transaction Amount
$6,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
